Bank of New York Mellon’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $832K | Buy |
|
|||||
|
2025
Q1 | $722K | Sell |
|
|||||
|
2024
Q4 | $521K | Sell |
|
|||||
|
2024
Q3 | $678K | Sell |
|
|||||
|
2024
Q2 | $1.57M | Buy |
|
|||||
|
2024
Q1 | $929K | Sell |
|
|||||
|
2023
Q4 | $687K | Buy |
|
|||||
|
2023
Q3 | $364K | Buy |
|
|||||
|
2023
Q2 | $387K | Sell |
|
|||||
|
2023
Q1 | $506K | Sell |
|
|||||
|
2022
Q4 | $874K | Buy |
|
|||||
|
2022
Q3 | $1.47M | Buy |
|
|||||
|
2022
Q2 | $869K | Buy |
|
|||||
|
2022
Q1 | $1.74M | Buy |
|
|||||
|
2021
Q4 | $2.73M | Sell |
|
|||||
|
2021
Q3 | $3.55M | Buy |
|
|||||
|
2021
Q2 | $4.65M | Sell |
|
|||||
|
2021
Q1 | $5.52M | Sell |
|
|||||
|
2020
Q4 | $7.52M | Sell |
|
|||||
|
2020
Q3 | $5.31M | Sell |
|
|||||
|
2020
Q2 | $5.43M | Buy |
|
|||||
|
2020
Q1 | $4.17M | Sell |
|
|||||
|
2019
Q4 | $8.54M | Buy |
|
|||||
|
2019
Q3 | $6.19M | Buy |
|
|||||
|
2019
Q2 | $5.76M | Buy |
|
|||||
|
2019
Q1 | $7.28M | Sell |
|
|||||
|
2018
Q4 | $7.73M | Sell |
|
|||||
|
2018
Q3 | $9.92M | Buy |
|
|||||
|
2018
Q2 | $11.6M | Buy |
|
|||||
|
2018
Q1 | $7.71M | Buy |
|
|||||
|
2017
Q4 | $3.63M | Sell |
|
|||||
|
2017
Q3 | $3.29M | Sell |
|
|||||
|
2017
Q2 | $2.84M | Buy |
|
|||||
|
2017
Q1 | $2.86M | Buy |
|
|||||
|
2016
Q4 | $1.97M | Buy |
|
|||||
|
2016
Q3 | $2.58M | Buy |
|
|||||
|
2016
Q2 | $2.67M | Buy |
|
|||||
|
2016
Q1 | $2.72M | Sell |
|
|||||
|
2015
Q4 | $3.94M | Buy |
|
|||||
|
2015
Q3 | $2.94M | Buy |
|
|||||
|
2015
Q2 | $3.58M | Sell |
|
|||||
|
2015
Q1 | $2.2M | Buy |
|
|||||
|
2014
Q4 | $1.06M | Sell |
|
|||||
|
2014
Q3 | $896K | Buy |
|
|||||
|
2014
Q2 | $1.04M | Buy |
|